Susan Hasty, Publisher
Table of Contents . . . February 3rd, 2003
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Biotech Business Week | Other Publications
Aerosolized Ricin - Company announces new developments on ricin toxin vaccine
Hypertension - Study: Decline in use ACE inhibitors, calcium channel blockers anticipated
Chronic Myeloid Leukemia - Glivec now available in Scotland
Collaborations - Exclusive rights to develop cancer targets acquired
Crohn Disease - Remicade granted priority review by FDA for use in maintaining fistula closure
Drug Development - Development of ETRX 101 discontinued
Abgenix, Inc. - Morphotek enters agreement to develop high-titer antibody cell lines
Ability Biomedical Corp. - Medarex enters collaboration to develop fully human antibody therapeutics
AmeriPath, Inc. - TriPath Oncology inks agreement to commercialize melanoma gene assay
AnVil, Inc. - Senior medical informaticist added to staff
Antifungal Therapy - Triad Therapeutics announces research collaboration
Aton Pharma, Inc. - $13.7M equity financing closed
BioInformatics, LLC - Survey looks at perceptions of brand in the life-science market
Biopure Corporation - Vice president of medical affairs named
Biotica Technology Limited - $5M raised in venture financing
Cell Robotics International - Record 4Q revenues, backorders predicted for 2003
Chromatin, Inc. - Hein named president, CEO
Collaborations - Agreement with Ortho-Clinical Diagnostics, Immunicon announced
Electronic Data Capture - Technology helps to deliver comprehensive infrastructure for clinical trials
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.